| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 4.663 | 11.179 | 8.069 | 14.381 | 9.589 | 0 | 0 |
| Total Income - EUR | - | - | - | 4.663 | 11.409 | 8.069 | 14.381 | 9.589 | 0 | 0 |
| Total Expenses - EUR | - | - | - | 1.004 | 2.172 | 1.857 | 2.127 | 1.606 | 168 | 291 |
| Gross Profit/Loss - EUR | - | - | - | 3.660 | 9.237 | 6.212 | 12.254 | 7.983 | -168 | -291 |
| Net Profit/Loss - EUR | - | - | - | 3.520 | 8.894 | 6.000 | 11.875 | 7.695 | -168 | -291 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Geoflor Cardiocons S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 139 | 105 | 72 | 40 | 10 | 0 | 0 |
| Current Assets | - | - | - | 3.522 | 12.381 | 18.318 | 27.547 | 35.728 | 35.483 | 35.284 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 253 | 0 | 0 | 41 | 40 | 30.195 |
| Cash | - | - | - | 3.522 | 12.128 | 18.318 | 27.547 | 35.688 | 35.442 | 5.089 |
| Shareholders Funds | - | - | - | 3.563 | 12.388 | 18.154 | 27.498 | 35.279 | 35.004 | 34.517 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 98 | 97 | 237 | 90 | 460 | 479 | 768 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Geoflor Cardiocons S.r.l.